- Home
- BCG vs IINN Comparison
BCG vs IINN Comparison
Compare BCG & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | IINN |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | Israel |
| Employees | 150 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6M | 35.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCG | IINN |
|---|---|---|
| Price | $1.69 | $0.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 80.2K | ★ 323.9K |
| Earning Date | 05-14-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16,841.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.36 | $0.34 |
| 52 Week High | $3.44 | $1.65 |
Technical Indicators
Market Signals| Indicator | BCG | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 35.88 | 33.73 |
| Support Level | $1.46 | $0.34 |
| Resistance Level | $1.90 | $0.63 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 5.62 | 7.98 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.